The Ink4a tumor suppressor gene product, p19(Arf), interacts with MDM2 and neutralizes MDM2's inhibition of p53

Jason Pomerantz, Nicole Schreiber-Agus, Nanette J. Liégeois, Adam Silverman, Leila Alland, Lynda Chin, Jason Potes, Ken Chen, Irene Orlow, Han Woong Lee, Carlos Cordon-Cardo, Ronald A. DePinho

Research output: Contribution to journalArticle

1254 Citations (Scopus)

Abstract

The INK4a gene encodes two distinct growth inhibitors - the cyclin- dependent kinase inhibitor p16(Ink4a), which is a component of the Rb pathway, and the tumor suppressor p19(Arf), which has been functionally linked to p53. Here we show that p19(Arf) potently suppresses oncogenic transformation in primary cells and that this function is abrogated when p53 is neutralized by viral oncoproteins and dominant-negative mutants but not by the p53 antagonist MDM2. This finding, coupled with the observations that p19(Arf) and MDM2 physically interact and that p19(Arf) blocks MDM2-induced p53 degradation and transactivational silencing, suggests that p19(Arf) functions mechanistically to prevent MDM2's neutralization of p53. Together, our findings ascribe INK4a's potent tumor suppressor activity to the cooperative actions of its two protein products and their relation to the two central growth control pathways, Rb and p53.

Original languageEnglish (US)
Pages (from-to)713-723
Number of pages11
JournalCell
Volume92
Issue number6
DOIs
StatePublished - Mar 20 1998

Fingerprint

Tumor Suppressor Genes
Tumors
Genes
Cyclin-Dependent Kinase Inhibitor p16
Growth Inhibitors
Oncogene Proteins
Neoplasms
Degradation
Growth
Proteins

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., ... DePinho, R. A. (1998). The Ink4a tumor suppressor gene product, p19(Arf), interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell, 92(6), 713-723. https://doi.org/10.1016/S0092-8674(00)81400-2

The Ink4a tumor suppressor gene product, p19(Arf), interacts with MDM2 and neutralizes MDM2's inhibition of p53. / Pomerantz, Jason; Schreiber-Agus, Nicole; Liégeois, Nanette J.; Silverman, Adam; Alland, Leila; Chin, Lynda; Potes, Jason; Chen, Ken; Orlow, Irene; Lee, Han Woong; Cordon-Cardo, Carlos; DePinho, Ronald A.

In: Cell, Vol. 92, No. 6, 20.03.1998, p. 713-723.

Research output: Contribution to journalArticle

Pomerantz, J, Schreiber-Agus, N, Liégeois, NJ, Silverman, A, Alland, L, Chin, L, Potes, J, Chen, K, Orlow, I, Lee, HW, Cordon-Cardo, C & DePinho, RA 1998, 'The Ink4a tumor suppressor gene product, p19(Arf), interacts with MDM2 and neutralizes MDM2's inhibition of p53', Cell, vol. 92, no. 6, pp. 713-723. https://doi.org/10.1016/S0092-8674(00)81400-2
Pomerantz J, Schreiber-Agus N, Liégeois NJ, Silverman A, Alland L, Chin L et al. The Ink4a tumor suppressor gene product, p19(Arf), interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell. 1998 Mar 20;92(6):713-723. https://doi.org/10.1016/S0092-8674(00)81400-2
Pomerantz, Jason ; Schreiber-Agus, Nicole ; Liégeois, Nanette J. ; Silverman, Adam ; Alland, Leila ; Chin, Lynda ; Potes, Jason ; Chen, Ken ; Orlow, Irene ; Lee, Han Woong ; Cordon-Cardo, Carlos ; DePinho, Ronald A. / The Ink4a tumor suppressor gene product, p19(Arf), interacts with MDM2 and neutralizes MDM2's inhibition of p53. In: Cell. 1998 ; Vol. 92, No. 6. pp. 713-723.
@article{2a62edee98484ff8879c831638f073a4,
title = "The Ink4a tumor suppressor gene product, p19(Arf), interacts with MDM2 and neutralizes MDM2's inhibition of p53",
abstract = "The INK4a gene encodes two distinct growth inhibitors - the cyclin- dependent kinase inhibitor p16(Ink4a), which is a component of the Rb pathway, and the tumor suppressor p19(Arf), which has been functionally linked to p53. Here we show that p19(Arf) potently suppresses oncogenic transformation in primary cells and that this function is abrogated when p53 is neutralized by viral oncoproteins and dominant-negative mutants but not by the p53 antagonist MDM2. This finding, coupled with the observations that p19(Arf) and MDM2 physically interact and that p19(Arf) blocks MDM2-induced p53 degradation and transactivational silencing, suggests that p19(Arf) functions mechanistically to prevent MDM2's neutralization of p53. Together, our findings ascribe INK4a's potent tumor suppressor activity to the cooperative actions of its two protein products and their relation to the two central growth control pathways, Rb and p53.",
author = "Jason Pomerantz and Nicole Schreiber-Agus and Li{\'e}geois, {Nanette J.} and Adam Silverman and Leila Alland and Lynda Chin and Jason Potes and Ken Chen and Irene Orlow and Lee, {Han Woong} and Carlos Cordon-Cardo and DePinho, {Ronald A.}",
year = "1998",
month = "3",
day = "20",
doi = "10.1016/S0092-8674(00)81400-2",
language = "English (US)",
volume = "92",
pages = "713--723",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - The Ink4a tumor suppressor gene product, p19(Arf), interacts with MDM2 and neutralizes MDM2's inhibition of p53

AU - Pomerantz, Jason

AU - Schreiber-Agus, Nicole

AU - Liégeois, Nanette J.

AU - Silverman, Adam

AU - Alland, Leila

AU - Chin, Lynda

AU - Potes, Jason

AU - Chen, Ken

AU - Orlow, Irene

AU - Lee, Han Woong

AU - Cordon-Cardo, Carlos

AU - DePinho, Ronald A.

PY - 1998/3/20

Y1 - 1998/3/20

N2 - The INK4a gene encodes two distinct growth inhibitors - the cyclin- dependent kinase inhibitor p16(Ink4a), which is a component of the Rb pathway, and the tumor suppressor p19(Arf), which has been functionally linked to p53. Here we show that p19(Arf) potently suppresses oncogenic transformation in primary cells and that this function is abrogated when p53 is neutralized by viral oncoproteins and dominant-negative mutants but not by the p53 antagonist MDM2. This finding, coupled with the observations that p19(Arf) and MDM2 physically interact and that p19(Arf) blocks MDM2-induced p53 degradation and transactivational silencing, suggests that p19(Arf) functions mechanistically to prevent MDM2's neutralization of p53. Together, our findings ascribe INK4a's potent tumor suppressor activity to the cooperative actions of its two protein products and their relation to the two central growth control pathways, Rb and p53.

AB - The INK4a gene encodes two distinct growth inhibitors - the cyclin- dependent kinase inhibitor p16(Ink4a), which is a component of the Rb pathway, and the tumor suppressor p19(Arf), which has been functionally linked to p53. Here we show that p19(Arf) potently suppresses oncogenic transformation in primary cells and that this function is abrogated when p53 is neutralized by viral oncoproteins and dominant-negative mutants but not by the p53 antagonist MDM2. This finding, coupled with the observations that p19(Arf) and MDM2 physically interact and that p19(Arf) blocks MDM2-induced p53 degradation and transactivational silencing, suggests that p19(Arf) functions mechanistically to prevent MDM2's neutralization of p53. Together, our findings ascribe INK4a's potent tumor suppressor activity to the cooperative actions of its two protein products and their relation to the two central growth control pathways, Rb and p53.

UR - http://www.scopus.com/inward/record.url?scp=0032549704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032549704&partnerID=8YFLogxK

U2 - 10.1016/S0092-8674(00)81400-2

DO - 10.1016/S0092-8674(00)81400-2

M3 - Article

VL - 92

SP - 713

EP - 723

JO - Cell

JF - Cell

SN - 0092-8674

IS - 6

ER -